Both in Pharmaceuticals
Braveheart Bio vs Agios Pharmaceuticals
Over the past year BRVE returned −29.8% and AGIO returned −6.8%; their daily moves had a correlation of -0.21.
BRVE −29.8% AGIO −6.8%Growth of $1, one year, split-adjusted
| Metric | BRVE | AGIO |
|---|---|---|
| Price | $18.71 | $31.32 |
| Market cap | $1.68B | $1.87B |
| Today | −4.30% | −3.09% |
| 1 month | −32.5% | −6.8% |
| 6 months | — | −10.9% |
| Year to date | — | +15.1% |
| 1 year | — | −24.3% |
| Revenue growth (YoY) | — | +259.3% |
| Gross margin | — | 93.3% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.0× |
| Net cash | — | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 40.1% |
| Short % of float | 7.3% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).